The absorption spectrum of the explosive 1,3,5-trinitro-1,3,5-triazacyclohexane (RDX) has been measured using a conventional Fourier transform infrared spectroscopy and by terahertz pulsed spectroscopy. Seven absorption features in the spectral range of 5–120cm−1 have been observed and identified as the fingerprint of RDX. Furthermore, the spatial distribution of individual chemical substances including RDX, has been mapped out using reflection terahertz spectroscopic imaging in combination with component spatial pattern analysis. This is the terahertz spectroscopy and chemical mapping of explosives obtained using reflection terahertz measurement, and represents a significant advance toward developing a terahertz pulsed imaging system for security screening of explosives.
Terahertz pulsed spectroscopy (TPS) and terahertz pulsed imaging (TPI) are two novel techniques for the physical characterization of pharmaceutical drug materials and final solid dosage forms, utilizing spectral information in the far infrared region of the electromagnetic spectrum. This review focuses on the development and performance of pharmaceutical applications of terahertz technology compared with other tools for physical characterization. TPS can be used to characterize crystalline properties of drugs and excipients. Different polymorphic forms of a drug can be readily distinguished and quantified. Recent developments towards a better understanding of the fundamental theory behind spectroscopy in the far infrared have been discussed. Applications for TPI include the measurement of coating thickness and uniformity in coated pharmaceutical tablets, structural imaging and 3D chemical imaging of solid dosage forms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.